Image
Practice Point
MDT treatment planning – Cardiac care
Close and early collaboration between oncologists and cardiologists is recommended for those patients that require treatment with a potentially cardiotoxic treatment, particularly in the context of existing cardiovascular disease or multiple cardiovascular risk factors.
Close and early collaboration between cardiologists, oncologists, haematologists and radiation oncologists is recommended to ensure lifelong CV health and to avoid unnecessary discontinuation of cancer therapy (Level of evidence III)
Strong evidence for efficacy with a substantial clinical benefit, strongly recommended
How this guidance was developed
No evidence-based source recommendation for this aspect of care was identified in early breast cancer specifically, however the inclusion of cardiac care was considered to be important for this guidance. This practice point was subsequently informed by a recommendation from the ESMO 2020 guidelines (Europe) on the management of cardiac disease throughout oncological treatment. The ESMO recommendation was based on a systematic review of the evidence to June 2018 and was graded ‘A’ using ESMO methods (i.e. according to the ESMO adapted Infectious Diseases Society of America-United States Public Health Service Grading System) by the source guideline authors.
Related guidance by topic
MDT treatment planning – Cardiac care
Practice Point
Close and early collaboration between oncologists and cardiologists is recommended for those patients that require treatment with a potentially cardiotoxic treatment, particularly in the context of existing cardiovascular disease or multiple cardiovascular risk factors.
Principles in action
Multidisciplinary care
Image
Care coordination
No evidence-based source recommendation for this aspect of care was identified in early breast cancer specifically, however the inclusion of cardiac care was considered to be important for this guidance. This practice point was subsequently informed by a recommendation from the ESMO 2020 guidelines (Europe) on the management of cardiac disease throughout oncological treatment. The ESMO recommendation was based on a systematic review of the evidence to June 2018 and was graded ‘A’ using ESMO methods (i.e. according to the ESMO adapted Infectious Diseases Society of America-United States Public Health Service Grading System) by the source guideline authors.
Related guidance by topic
Image
Wellbeing & psychosocial care
Image
Older patients
Image
